News
Review abstracts, posters, oral comunications, plenary sessions and invited lectures related to our research programs, lab services, partner collaborations and other topics related to our science

Expanded and activated TILs kill tumor cells enabling IO compound assays

35th Anniversary Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2020)
2020 November
Virtual Congress
Poster Presentation

Bispecific T-cell engager antibodies may contribute to reactivate pre-existing Tumor specific T-Cells

25th CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2020 June
Virtual Congress
Poster Presentation

NKG2D Chimeric Antigen Receptor-Expressing Lymphocytes Target Acute Myeloid Leukemia Cells

61st ASH ANNUAL MEETING
2019 December
Orlando, FL, USA
Poster Presentation

Immuno-Oncology Functional Precision Medicine Assays by Trogocytosis

FUNCTIONAL PRECISION MEDICINE SUMMIT (AS PART OF AACR ANNUAL MEETING)
2019 April
Atlanta, USA
Poster presentation

In Vitro Characterization of TP-2846: A Novel Tetracycline Antileukemia Agent

AACR ANNUAL MEETING
2019 April
Atlanta, USA
Poster presentation

A New Mechanism for Bispecific T-Cell Engagers Reactivating Tumor-Selective T Cells in Acute Leukemia

BULGARIAN CONGRESS OF CLINICAL IMMUNOLOGY
2018 October
Plovdiv, Bulgaria
Invited Lecture

Evaluation of the Activity of IMiDS in MM Proliferating Cells

23RD CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2018 June
Stockholm, Sweden
Poster presentation

Mode of Cytotoxic Action of T-Cell Bispecific Antibodies on Hematological Malignancies: a Novel In Vitro Approach

ESH 4TH INTERNATIONAL CONFERENCE ON ACUTE MYELOID LEUKEMIA “MOLECULAR AND TRANSLATIONAL”: ADVANCES IN BIOLOGY AND TREATMENT
2017 October
Estoril, Portugal
Poster presentation

A New Mechanism of Action for Bispecific Antibodies Activating Tumor-Specific Antigen T Cells

8TH ANNUAL WORLD BISPECIFIC SUMMIT
2017 September
Boston, MA
Conference speaker

A Novel Method to Capture the Pharmacological Activity of Bispecific Antibodies in Patients with Hematological Malignancies

THIRD CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE. TRANSLATING SCIENCE INTO SURVIVAL
2017 September
Mainz, Frankfurt
Poster presentation

Validation of Precision Medicine Test for Acute Myeloid Leukemia in an Observational Clinical Trial

22ND CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2017 June
Madrid, Spain
Poster presentation

A Novel In Vitro Method to Quantify the Pharmacology Activity of Bispecific Antibodies in Hematological Samples

22ND CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2017 June
Madrid, Spain
Poster presentation

A New Precision Medicine Test to Guide Personalized Treatments Decision for Acute Myeloid Leukemia Patients

AACR HEMATOLOGIC MALIGNANCIES: TRANSLATING DISCOVERIES TO NOVEL THERAPIES
2017 May
Boston, MA
Poster presentation

Pharmacological Evaluation of Bispecific Antibodies: A Novel Method to Quantify their In Vitro Activity in Hematological Samples

AACR HEMATOLOGIC MALIGNANCIES: TRANSLATING DISCOVERIES TO NOVEL THERAPIES
2017 May
Boston, MA
Poster presentation

An Ex Vivo Native Environment Precision Medicine Test Shows High Clinical Correlation with Responses to First Line Acute Myeloid Leukemia Treatment

5TH INTERNATIONAL CONFERENCE ON PREDICTIVE, PREVENTIVE AND PERSONALIZED MEDICINE & MOLECULAR DIAGNOSTICS
2016 December
Valencia, Spain
Conference speaker

A Novel Native Environment Method for Evaluating Immune-Oncology Compounds by Flow Cytometry

PHARMACEUTICAL FLOW CYTOMETRY & IMAGING
2016 November
Stevenage, UK
Poster presentation

Prediccion de Respuesta al Tratamiento en Leucemia Mieloide Aguda: Perfil Mutacional (NGS) y Test Farmacológico Ex Vivo

LVIII CONGRESO NACIONAL SEHH
2016 October
Santiago de Compostela, Spain
Oral comunication

Test Ex Vivo de Sensibilidad a Tratamientos en la Leucemia Mieloblastica Aguda

JORNADA DE ACTUALIZACIÓN EN EL TRATAMIENTO DE LA LEUCEMIA AGUDA
2016 September
Madrid, Spain
Oral comunication

A New Mechanism of Action for Bispecific Antibodies Activating Tumor- Specific Antigen T Cells

7TH ANNUAL WORLD BISPECIFIC SUMMIT
2016 August
Boston, MA
Conference speaker

ExVivo Lymph Node Native Microenvironment Assay Shows Novel Antiproliferative Activity for Idelalisib and Ibrutinib on CLL Cells

21ST CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2016 June
Copenhagen, Denmark
Poster presentation

An Ex Vivo Native Environment Precision Medicine Test Shows High Clinical Correlation with Responses to 1st Line Acute Myeloid Leukemia Treatment

21ST CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2016 June
Copenhagen, Denmark
Poster presentation

An Ex Vivo Native Environment Precision Medicine Test Shows High Clinical Correlation with Responses to 1st Line Acute Myeloid Leukemia Treatment

7TH INTERNATIONAL HEMATOLOGIC MALIGNANCIES CONFERENCE: BRIDGING THE GAP 2016 (BTG2016)
2016 February
Guangzhou, China
Poster presentation

ExVivo Lymph Node Native Microenvironment Assay Shows Novel Antiproliferative Activity for Idelalisib and Ibrutinib on CLL Cells

7TH INTERNATIONAL HEMATOLOGIC MALIGNANCIES CONFERENCE: BRIDGING THE GAP 2016 (BTG2016)
2016 February
Guangzhou, China
Poster presentation

Precision Medicine in Native Environment

LABCYTE SYMPOSIUM, ADVANCING LIFE SCIENCES RESEARCH WITH ACOUSTIC LIQUID HANDLING
2015 October
Boston, MA
Invited Lecture

High Correlation between Clinical Responses to 1st Line AML Patients Treated with Cytarabine and Idarubicin and their Pharmacological Profiles in Patient Samples Measured by ExviTech

ESH, INTERNATIONAL CONFERENCE ON AML “MOLECULAR AND TRANSLATIONAL” ADVANCES IN THE BIOLOGY AND TREATMENT
2015 September
Budapest, Hungary
Poster presentation

Native Environment Precision Medicine of Bispecific Immunotherapy Antibodies

6TH ANNUAL WORLD BISPECIFIC SUMMIT
2015 August
Boston, MA
Poster presentation

Pharmacological Profiles of AML Treatments in Patient Samples to Personalize Treatment

19TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2014 June
Milan, Italy
Poster presentation

The Effect of Bortezomib on Different Cell Subsets: an Approach for an Individual Personalized Medicine

19TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2014 June
Milan, Italy
Poster presentation

Preclinical Antimyeloma Activity of the Alkylating-HDACi Fusion Molecule EDO-S101 through DNA-Damaging and HDACi Effects

19TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2014 June
Milan, Italy
Poster presentation

Potential Hematotoxicity of New Drug Candidates Measured in Hematopoietic Progenitors in Bone Marrow Samples

19TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2014 June
Milan, Italy
Poster presentation

Pharmacological Evaluation of Drugs & Combinations in Patient Samples of Hematological Malignancies by Automated Flow Cytometry

19TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2014 June
Milan, Italy
Poster presentation

Pharmacological Evaluation of Drugs & Combinations in Patient Samples of Hematological Malignancies by Automated Flow Cytometry

15TH DRUG DISCOVERY SUMMIT, 4TH DRUG DEVELOPMENT CONGRESS AND 2ND DISCOVERY CHEMISTRY & DRUG DESIGN CONGRESS
2014 June
Geneva, Switzerland
Poster presentation

Hematotoxicity Potential of New Drug Candidates Measured in Hematopoietic Progenitors in Bone Marrow Samples

15TH DRUG DISCOVERY SUMMIT, 4TH DRUG DEVELOPMENT CONGRESS AND 2ND DISCOVERY CHEMISTRY & DRUG DESIGN CONGRESS
2014 June
Geneva, Switzerland
Poster presentation

Clinically Validated Screening of Compounds in Patient Samples for Efficacy & Hematotoxicity

13TH ANNUAL WORLD PHARMA CONGRESS
2014 May
Boston, MA
Conference speaker

Test ExVivo de Medicina Personalizada para Predecir la Respuesta a la Primera Línea de Inducción con Idarubicina y Citarabina en Pacientes de Leucemia Mieloide Aguda

LV CONGRESO NACIONAL DE LA SEHH-XXIX CONGRESO NACIONAL DE LA SETH
2013 October
Seville, Spain
Oral comunication

Perfiles Farmacológicos Ex Vivo de 11 Fármacos en más de 60 Muestras de Médula Ósea de Pacientes con Leucemia Mieloide Aguda

LV CONGRESO NACIONAL DE LA SEHH-XXIX CONGRESO NACIONAL DE LA SETH
2013 October
Seville, Spain
Poster presentation

Perfiles Farmacológicos Ex Vivo de 16 Fármacos en 23 Muestras de Medula Ósea de Pacientes con Leucemia Linfoblástica Aguda

LV CONGRESO NACIONAL DE LA SEHH-XXIX CONGRESO NACIONAL DE LA SETH
2013 October
Seville, Spain
Poster presentation

Perfiles Farmacológicos Ex Vivo de 17 Fármacos en más de 50 Muestras de Medula Ósea de Pacientes con Mieloma Múltiple

LV CONGRESO NACIONAL DE LA SEHH-XXIX CONGRESO NACIONAL DE LA SETH
2013 October
Seville, Spain
Poster presentation

Ex Vivo Pharmacological Evaluation of 16 Drugs in 75+ Acute Myeloid Leukemia Patients Using Whole Bone Marrow Samples Analyzed by Automated Flow Cytometry

18TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
2013 June
Stockholm, Sweden
Poster presentation

Modelling and Simulation Applied to Personalised Medicine

POPULATION APPROACH GROUP IN EUROPE
2013 June
Glasgow, Scotland
Poster presentation

Evaluación de la Actividad Ex Vivo de Bortezomib en Muestras de Pacientes con Mieloma Múltiple (MM)

LIV REUNIÓN NACIONAL DE LA SEHH XXVIII CONGRESO NACIONAL DE LA SETH
2012 October
Salamanca, Spain
Poster presentation

Análisis Comparativo de los Resultados Obtenidos en Tests de Medicina Personalizada Realizados en Muestra de Sangre Periférica vs Congelada

XII CONGRESO DE LA SOCIEDAD IBÉRICA DE CITOMETRÍA
2011 May
Bilbao, Spain
Poster presentation

Análisis Comparativo de los Resultados Obtenidos en Test Ex Vivo Mediante Citometría de Flujo vs Test TRAC

XII CONGRESO DE LA SOCIEDAD IBÉRICA DE CITOMETRÍA
2011 May
Bilbao, Spain
Poster presentation

Personalized Medicine Test of Multi-Drug Protocolos Ex Vivo for Hematological Malignancies

51ST ASH ANNUAL MEETING
2009 December
New Orleans, LA
Poster presentation

Screening Thousands of Drugs in Leukemia Patient Samples to Identify Novel Uses for Approved Drugs

51ST ASH ANNUAL MEETING
2009 December
New Orleans, LA
Poster presentation